Clinical Trials Browser

Phase 2 × mirdametinib × Thoracic × Clear all

NCT00174369 2009-03-17

MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung